Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemically Recurrent”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Study completedNCT02649439
What this trial is testing

Prostvac in Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 97
Testing effectiveness (Phase 2)Looking for participantsNCT04700332
What this trial is testing

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 184
Testing effectiveness (Phase 2)Active Not RecruitingNCT03637543
What this trial is testing

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 29
Testing effectiveness (Phase 2)WithdrawnNCT04585932
What this trial is testing

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaOligometastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07073794
What this trial is testing

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocally Advanced Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Mayo Clinic 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04777071
What this trial is testing

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma+3 more
University of Washington 141
Large-scale testing (Phase 3)Active Not RecruitingNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Testing effectiveness (Phase 2)Looking for participantsNCT06378866
What this trial is testing

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Who this might be right for
Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more
Mayo Clinic 532
Testing effectiveness (Phase 2)Active Not RecruitingNCT04206319
What this trial is testing

Radium-223 in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemical Recurrent Prostate Cancer
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT03315871
What this trial is testing

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Temporarily pausedNCT04519879
What this trial is testing

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Who this might be right for
Prostate AdenocarcinomaPSA FailurePSA Progression+7 more
City of Hope Medical Center 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT05320406
What this trial is testing

RElugolix VErsus LeUprolide Cardiac Trial

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaStage I Prostate Cancer AJCC v8+8 more
Emory University 94
Testing effectiveness (Phase 2)Ended earlyNCT00058214
What this trial is testing

Perifosine in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT02020070
What this trial is testing

Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer
Memorial Sloan Kettering Cancer Center 16
Not applicableStudy completedNCT04447703
What this trial is testing

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaStage IIIB Prostate Cancer AJCC v8+2 more
Thomas Jefferson University 346
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Testing effectiveness (Phase 2)Study completedNCT01054079
What this trial is testing

Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
Wake Forest University Health Sciences 20
Early research (Phase 1)Active Not RecruitingNCT06105918
What this trial is testing

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
Emory University 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906
What this trial is testing

Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 985
Testing effectiveness (Phase 2)Looking for participantsNCT05054296
What this trial is testing

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 200
Next Page